Home > News > Calando Receives a Vote of Confidence
April 3rd, 2006
Calando Receives a Vote of Confidence
Abstract:
Jack Uldrich: Today, Arrowhead (Nasdaq: ARWR) announced that it was investing $10 million in Calando to help the company accelerate preclinical testing of it RNAi therapeutics. This is a major vote of confidence in the potential of Calando’s technology, and I continue to be intrigued by Arrowhead’s business model of buying up promising intellectual property with an eye toward commercializing it.
Source:
NanoNovus
Bookmark:
Investments/IPO's/Splits
Dr. Ben J. Lipps designated as Chairman of the Management Board and Chief Executive Officer of Nanostart-holding MagForce AG June 17th, 2013
Harris & Harris Group Notes Carl Zeiss' Planned Acquisition of Xradia June 13th, 2013
Long Island Capital Alliance Announces Participants for Biotech Technology Transfer Capital Forum: Event to Be Held on June 14 in Collaboration With Cold Spring Harbor Laboratory June 8th, 2013
Iran to Hold Int'l Forum on Nanotechnology Economy (IFNE2013) May 30th, 2013
Announcements
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
New Method to Synthesize Zinc Oxide Nanoparticles with High Catalytic Activity June 18th, 2013
Production of Polyaniline Biosensors Modified with Conductive Polymer Composites June 18th, 2013